Bacterial Vaginosis
144
8
11
97
Key Insights
Highlights
Success Rate
94% trial completion (above average)
Published Results
30 trials with published results (21%)
Research Maturity
97 completed trials (67% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
4.2%
6 terminated out of 144 trials
94.2%
+7.7% vs benchmark
32%
46 trials in Phase 3/4
31%
30 of 97 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 97 completed trials
Clinical Trials (144)
Impact of Clinician-administered Vaginal Live Biotherapeutic Product
Study to Evaluate Efficacy and Safety of Gyntima® Balance in Preventing Recurrences of Bacterial Vaginosis
Point of Care Diagnosis of Vaginal Infections
The LISA (Lactoferrin InStead of Antibiotics/Antifungals) Feasibility Study
Efficacy and Safety Study of BPR-101 Capsules in Combination With Metronidazole in BV Patients
Exploring the Effects of an Intravaginal Lactic Acid Gel on the Vaginal Microbiome
Live Double Combined Lactobacillus Capsule for Vaginal Use(IIb)
Light Treatment of Vaginal Infections in Reproductive Age Women
Single Arm Trial of Menstrual Cups Among Economically Vulnerable Women to Reduce Bacterial Vaginosis and STIs
A First-in-Human Safety and Pharmacokinetic Trial of GenSci142 Administered as Single Ascending Doses in Healthy Chinese Women
Prospective Data Bank Creation to Study Vaginal Conditions
Title of the Protocol: Combined Use of Vaginal Clindamycin Cream and Oral Metronidazole Versus Oral Metronidazole
Performance and Safety of Lactal Gel for Treatment of Bacterial Vaginosis
Clinical Study of a Vaginal Gel for the Treatment and Prevention of Vaginal Infections
Kinetics and Ecology of Human Papillomavirus Genital Infections in Young Women
Genital Tract Infections, the Vaginal Microbiome and Gestational Age at Birth Among Pregnant Women in South Africa
Serial Screening and Treatment of Bacterial Vaginosis Trial
A First-in-human Safety Trial of BNT331 Administered as Single Ascending Doses in Healthy Women and as Multiple Ascending Doses in Women Diagnosed With Bacterial Vaginosis
Screening With Tampons: Evaluating Diagnostic Accuracy and HPV and Assessing Participant Views
Lacticaseibacillus Rhamnosus CA15 (DSM 33960) Strain as a New Driver in Restoring the Normal Vaginal Microbiota